Published in Medical Letter on the CDC and FDA, June 30th, 2002
The World Health Organization (WHO) and ADA provide diagnostic guidelines for diabetes and pre-diabetes conditions. The two organizations differ significantly in their reliance on the oral glucose tolerance test (OGTT) as a diagnostic tool. ADA recommends that fasting plasma glucose values are sufficient for diagnosis and discourages OGTT. WHO, on the other hand, argues strongly to retain routine OGTT in diagnostic situations unless...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.